Health Condition 1: N99- Intraoperative and postproceduralcomplications and disorders of genitourinary system, not elsewhere classified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. ASA I and II patients of either sex. 2.Patients aged between 20 to 50 years 3. Patients undergoing elective ureteroscopic surgeries.
Exclusion criteria
Exclusion criteria: 1.Patients with known hypersensitivity to local anaesthetic drugs. 2.Pregnant and lactating women. 3.Patients refusal 4.Local site infection and peripheral vascular disease. 5.Diagnosed to have neurological disease. 6.Patients with severe cardiovascular, respiratory, hepatic and renal disease. 7.Patients with coagulation abnormalities. 8.Patients with previous spine surgeries, and spine abnormalities.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the effect of adding 1.6 mg Nalbuphine to 0.5 % Levobupivacaine heavy for ureteroscopic surgeries under spinal anaesthesia for evaluating the duration of analgesia.Timepoint: 0,1,3,5,10 minutes | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects if anyTimepoint: 0,1,3,5,10 minutes | — |
Countries
India
Contacts
Rajarajeswari medical college and hospital